天堂网亚洲,天天操天天搞,91视频高清,菠萝蜜视频在线观看入口,美女视频性感美女视频,95丝袜美女视频国产,超高清美女视频图片

Welcome to chemicalbook!
+1 (818) 612-2111
Inquriy
Try our best to find the right business for you.
Do not miss inquiry messages Please log in to view all inquiry messages.

Welcome back!

RFQ
skype
MY Account
Top
Postion:Product Catalog >API>Hormones and the Endocrine System>Pancreatic hormone and blood sugar regulation>Glimepiride
Glimepiride
  • Glimepiride

Glimepiride NEW

Price $54
Package 500mg
Min. Order:
Supply Ability: 10g
Update Time: 2024-11-19

Product Details

Product Name: Glimepiride CAS No.: 93479-97-1
Purity: 99.97% Supply Ability: 10g
Release date: 2024/11/19

Product Introduction

Bioactivity

NameGlimepiride
DescriptionGlimepiride (HOE-490) is a long-acting, third-generation sulfonylurea with hypoglycemic activity.
In vitroIn both normal and insulin-resistant adipocytes, as well as in myocytes, Glimepiride effectively stimulates glucose transport, and the synthesis of lipids and glycogen. In cardiomyocytes, Glimepiride (IC50=6.8 nM) inhibits the pinacidil-activated whole-cell K(ATP) current. Additionally, in HEK 293 cells, Glimepiride (IC50=6.2 nM) blocks the K(ATP) channels formed by the co-expression of Kir6.2/SUR2A subunits.
In vivoWithin diabetic rats, Glimepiride has been shown to decrease the incidence of sperm abnormalities, enhance sperm count, and bolster antioxidant capacity.
StoragePowder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice.
Solubility InformationDMSO : 16.67 mg/mL (33.97 mM)
KeywordsInhibitor | HOE490 | Glimepiride | HOE 490 | inhibit
Inhibitors RelatedMinoxidil sulfate | Glibenclamide | (±)-Naringenin | Tolbutamide | Tetraethylammonium bromide | Halothane | Butamben | Cloperastine hydrochloride | 2,2,2-Trichloroethanol | Indapamide
Related Compound LibrariesPain-Related Compound Library | Bioactive Compound Library | EMA Approved Drug Library | Anti-Cancer Clinical Compound Library | Drug Repurposing Compound Library | FDA-Approved Drug Library | Anti-Cancer Approved Drug Library | Bioactive Compounds Library Max | Ion Channel Targeted Library | Anti-Cancer Drug Library

Company Profile Introduction

Target Molecule Corp. (TargetMol) is a global high-tech enterprise, headquartered in Boston, MA, specializing in chemical and biological research product and service to meet the research needs of global customers. TargetMol has evolved into one of the biggest global compound library and small molecule suppliers and a customer based on 40+ countries. TargetMol offers over 80 types of compound libraries and a wide range of high-quality research chemicals including inhibitors, activator, natural compounds, peptides, inhibitory antibodies, and novel life-science kits, for laboratory and scientific use. Besides, virtual screening service is also available for customers who would like to conduct the computer-aided drug discovery.

You may like

Recommended supplier

Product name Price   Suppliers Update time
$54.00/500mg
VIP5Y
TargetMol Chemicals Inc.
2024-11-19
$10.00/1KG
VIP6Y
Hebei Weibang Biotechnology Co., Ltd
2024-11-18
$0.00/1KG
VIP3Y
Hebei Weibang Biotechnology Co., Ltd
2024-11-01
$6.00/1kg
VIP4Y
Hebei Chuanghai Biotechnology Co,.LTD
2024-08-21
$0.00/1kg
VIP2Y
Hebei Kingfiner Technology Development Co.Ltd
2024-06-18
$0.00/25kg
VIP1Y
PUSHAN INDUSTRIAL (SHAANXI) CO.,LTD
2024-05-17
$0.00/1kg
VIP1Y
Shaanxi TNJONE Pharmaceutical Co., Ltd
2024-04-29
$0.00/1kg
Nanjing Fred Technology Co., Ltd
2024-01-04
$0.00/25KG
VIP5Y
Hebei Mojin Biotechnology Co., Ltd
2023-06-20
$100.00/1kg
Shijiazhuang Gantuo Biotechnology Co., Ltd
2023-03-09
  • Since: 2011-01-07
  • Address: 36?Washington?Street, Wellesley?Hills
INQUIRY